Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)

Only a Little More Upside Left

You may want to start taking profits now. Plus, charts of AOL, Intel and more.

Economy Reasserts Its Presence

Economy Reasserts Its Presence

Traders might take the jobs report today as an opportunity to focus on economic fundamentals again.

Breakouts and Breakdowns From A to Z

Take a look at charts from Apache and Advanced Fibre to Zimmer and more.

Rallying Back to Resistance

The market recovered after a terror scare in New York, and the indices look ready for another leg up next week.

Being in Cash Might Be Best for Now

That's what these charts are indicating. Plus, Nokia, Expedia and more.

Equipment Makers Have Cause to Fear Pharma Consolidation

Equipment Makers Have Cause to Fear Pharma Consolidation

Some of the projected savings from big deals such as Pfizer-Pharmacia may come from equipment orders.

The Night Watch: Tyco Keeps Climbing

The Night Watch: Tyco Keeps Climbing

Polymedica is falling after offering revenue guidance.

Choking on a Foolish Short

Cramer follows up on a Motley Fool's misguided recommendation to short Affymetrix.

10 No-Future Stocks I'd Dump Now

10 No-Future Stocks I'd Dump Now

A whole array of star stocks crashed last year; here's some rules to decide which ones to toss.

Bad News Sends Biotech Sliding

The sector's bulls feel the same disappointment as Amgen, Praecis and Affymetrix.

Waters' Warning Runs Downhill, Soaking Biotech Equipment Makers

Waters' Warning Runs Downhill, Soaking Biotech Equipment Makers

The news has analysts rethinking rosy assumptions about the short-term health of this group.

Today's Market: Investors Add to Yesterday's Late-Day Rally

Today's Market: Investors Add to Yesterday's Late-Day Rally

Wall Street digests a 0.1% rise in May's retail sales. Kraft is up some 2% as it begins trading.

Affymetrix Tumbles Amid a Glut of Downgrades After Monday's Warning

Affymetrix Tumbles Amid a Glut of Downgrades After Monday's Warning

Analysts are concerned with a lack of visibility, but most see a bright spot in the firm's dominant position.

Biotech Affymetrix Warns of Wider-Than-Expected Loss

Biotech Affymetrix Warns of Wider-Than-Expected Loss

Due to slow sales, the equipment maker says it will lose far more than the penny a share that's expected.

The Sentiment Is All Bull(ish) While the Statements on Inflation Are Bull

The Sentiment Is All Bull(ish) While the Statements on Inflation Are Bull

Task's inner cynic is cringing at this market and crying out for some healthy skepticism.

Gene Logic Has It

There is considerable interest in what this genomic company has to offer.

Applied Biosystems at the Bottom of the Big Board's Steepest Slide

Applied Biosystems at the Bottom of the Big Board's Steepest Slide

Sky-high valuation and a revenue warning make it the NYSE's worst quarterly performer.

Biotech Start-Up Banks on Big Names as IPO Approaches

Biotech Start-Up Banks on Big Names as IPO Approaches

GMP boasts an ample supply of biotech stars but little in terms of revenue or product. Is this market ready for this deal?

Beware the Biotech Bubble

Beware the Biotech Bubble

This sector, up huge in recent months, has been prone to excess -- and steep drops -- before.

Affymetrix Jumps 20% on License-Dispute Victory

Affymetrix Jumps 20% on License-Dispute Victory

A U.K. appeals court reverses an earlier ruling.

Competition Worries Put Affymetrix on the Defensive

Competition Worries Put Affymetrix on the Defensive

But the biotech firm is fighting back with new products and questions about rivals' offerings.